LinkedIn

The congress is the single most focused event in Europe dedicated to key technological and scientific trends in GPCR’s in the pharmaceutical and biotech industry, as well as academic institutions. It will also be co-located with our 11th Annual Drug Discovery Summit. G-protein coupled receptors have proven to be a highly amenable target class to successful therapeutic intervention via small-molecule drugs. GPCRs represent 25% of the total pharmaceutically-addressed drug targets today and therefore are the most-druggable target family. This conference explores effective strategies, technologies and applications of GPCR in accelerating drug targeting, discovery and early development. Over two days, the 2 events will attract over 150 senior-level decision makers working in drug targeting, design, discovery and development from the UK, Europe and US. This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment. Day 1 GPCR MODULATION Closer studies into various aspects of GPCR’s including allosteric modulations from both a chemistry and biology aspect, dimerisation and oligomerisation GPCR SIGNALLING & DISCOVERY GPCR PROGRAMMES Latest approaches to other important aspects of GPCR’s - including the role of signaling and trafficking, functional selectivity, polypharmacology and Drug Discovery Programmes Day 2 GPCR SCREENING Examining the implementation of GPCR screening methods, HTS, HCS as well as exploring the roles of cell and label free screening, assay technology as well as determining cost effective assay formats. STRUCTURE & IN SILICO Focus upon the optimization of all areas of GPCR medicinal chemistry including structure, mechanism, SAR, protein and ligand structure based drug design and molecular and in silico modelling